Skip to main content
. 2017 Jul 20;13(3):495–500. doi: 10.2215/CJN.12011116

Table 2.

Proposed secondary outcomes in dialysis catheter trials

Catheter dysfunction
Use of thrombolytic therapy
Antimicrobial resistance—not just of clinical isolates but also of surveillance cultures
Catheter removal
All-cause hospitalization or hospitalization due to infection
Systemic antimicrobial use/exposure
Death
Any adverse events directly related to the drug on the patient or catheter integrity
Cost of care
Quality of life